Pharmaceutical

GRIT and Quangang announce IL-2 T-cell therapy partnership

GRIT has formed a strategic partnership with Quangang Pharmaceutical (Quangang) to enhance research for solid tumour patients in China.

Jun 4, 2024 - 04:00
GRIT and Quangang announce IL-2 T-cell therapy partnership
GRIT has formed a strategic partnership with Quangang Pharmaceutical (Quangang) to enhance research for solid tumour patients in China.
Read the original article

Tags:

Previous Article

Lilly strikes deal with QurAlis for preclinical ALS candidate

Next Article

CHMP approves backing for first acanthamoeba keratitis treatment

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Novartis touts breast cancer win with “landmark” Kisqali results

Novartis touts breast cancer win with “landmark” Kisqal...

Jun 3, 2023

How an immunological Trojan horse could treat disease

How an immunological Trojan horse could treat disease

Jan 30, 2024

Jazz Pharma’s Enrylaze wins European approval for AML and LBL

Jazz Pharma’s Enrylaze wins European approval for AML a...

Sep 23, 2023